Trial Profile
A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2017
Price :
$35
*
At a glance
- Drugs Atezolizumab (Primary)
- Indications Alveolar soft part sarcoma
- Focus Therapeutic Use
- 02 Aug 2017 New trial record